TG Therapeutics Is Maintained at Overweight by JP Morgan

Dow JonesNov 25 22:32 · Ratings

TG Therapeutics Analyst Ratings

BenzingaNov 25 22:22 · Ratings

J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43

Futu NewsNov 25 20:39 · Ratings

A Closer Look at TG Therapeutics's Options Market Dynamics

BenzingaNov 22 01:18

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500

GlobeNewswireNov 21 19:00

10 Health Care Stocks Whale Activity In Today's Session

BenzingaNov 13 01:35